Back to search

Accelerated hypofractionation for early-stage non-small-cell lung cancer

Data up to Jan 2025

Published2002
Citations65
References25

Total Citations Per Year

Abstract

References (25)

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

1995 • 2,739 citations

Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial

1996 • 927 citations

Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer

2000 • 635 citations

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial

1999 • 486 citations

Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke Experience

1998 • 347 citations

Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients

1999 • 333 citations

Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial

2001 • 324 citations

What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?

1998 • 272 citations

Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography

1990 • 264 citations

Interruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trials

1993 • 230 citations

Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation?

1996 • 213 citations

Elective nodal irradiation in the treatment of non–small-cell lung cancer with three-dimensional conformal radiation therapy

2001 • 186 citations

Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication

1993 • 162 citations

Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone

1996 • 118 citations

Limited field irradiation in early stage (T1–2N0) non-small cell lung cancer

1996 • 102 citations

Involved-field radiotherapy alone for early-stage non–small-cell lung cancer

2000 • 98 citations

Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable)

2015 • 92 citations

Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable)

2001 • 91 citations

73.6 Gy and Beyond: Hyperfractionated, Accelerated Radiotherapy for Non–Small-Cell Lung Cancer

2001 • 80 citations

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.

2000 • 77 citations

The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer

2000 • 68 citations

Impact of beam energy and field margin on penumbra at lung tumor-lung parenchyma interfaces

1998 • 47 citations

Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer

1996 • 32 citations

Surgical management of early stage lung cancer

2000 • 17 citations

Modeling tumor and treated lung volume influences in the irradiation of non–small-cell lung cancer patients

2001 • 11 citations

Cited By (0)

Loading...
Accelerated hypofractionation for early-stage non-small-cell lung cancer (2002) – International Journal of Radiation Oncology*Biology*Physics | Metascience Observatory Explorer